AXA SA (AXAHY) AI Stock Analysis

Company Guidance

Management reiterated confidence in delivering full‑year 2026 underlying earnings per share (UEPS) growth at the upper end of its 6–8% target range, after reporting H1 results including organic top‑line growth +5%, UEPS +8% (underlying earnings +4% at group level, +9% excl. AXA IM), return on equity 18% and a Solvency II ratio of 218% (215% at Jan 1, H1 movement: +17 pts normalized capital generation, −12 pts dividends/buybacks, −3 pts economic variance). They highlighted strong P&C momentum — earnings +6%, combined ratio 90.1% (↑10bps YoY, +30bps ex‑Prima, Nat Cat 3.5% vs a normalized 4.5%), non‑commission expense 9.7% (40bps improvement) and low PYD reliance (−1pt) — and said investment income is a tailwind supported by reinvestment at ~4.6%. AXA XL earnings grew +4% with pricing contained at about −1% and ~30bps benefit from lower reinsurance; Life & Health premiums +8% and earnings +11% (short‑term revenues +5%, technical margin +53%, combined ratio 96%, long‑term net flows up from €2.2bn to €3.0bn, CSM release +6% with FY26 CSM release guidance >3%). They also confirmed cash remittance ambitions above €21bn for the plan, ~€10bn mid‑market lending exposure (avg ticket €7–8m), Prima pro‑forma combined ratio ~87.5% with ~€2bn reserves and target to recapture ~90% of Prima premiums by 2027 (≈€0.9bn recapture expected in 2026), and continued cost‑efficiency delivery (group non‑commission expense rollback ~30bps in 2026 and −50bps target over the plan).